Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Focal Adhesion Protein-Tyrosine Kinases × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

pembrolizumab 546 Specimen Handling 511 Magnetic Resonance Spectroscopy 441 Carboplatin 359 Cyclophosphamide 329 Biopsy 305 Cisplatin 300 Paclitaxel 265 Nivolumab 256 Gemcitabine 232 Radiotherapy 222 Bevacizumab 197 Dexamethasone 190 venetoclax 179 fludarabine 179 Oxaliplatin 160 Docetaxel 157 Fluorouracil 155 durvalumab 151 atezolizumab 151 Rituximab 148 Pemetrexed 147 Capecitabine 139 Doxorubicin 136 Radiation 132 Lenalidomide 124 Prednisone 123 Standard of Care 120 Radiosurgery 119 Drug Therapy 118

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05695508 2025-12-24

HD10/DSMMXX

University of Heidelberg Medical Center

Phase 2 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡